Table 2.

Statistical table for pairwise comparisons for post hoc tests

Figures	Outcome	Group level	Contrast	Estimate	95% CI	SEM	Degrees of freedom	t	p	Row
1B	Dam mass		STD - LBN	−1.23	[−2.36, −0.10]	0.562	47.0	−2.20	0.033	1
			PND4 - PND11	−2.78	[−3.33, −2.22]	0.227	94.0	−12.21	<0.001	2
			PND4 - PND21	−2.15	[−2.70, −1.59]	0.227	94.0	−9.45	<0.001	3
			PND11 - PND21	0.63	[0.07, 1.18]	0.227	94.0	2.76	0.007	4
2B	PND11 mass		STD - LBN	0.55	[0.17, 0.94]	0.192	47.0	2.87	0.006	5
2C	Male mass	PND 11	STD - LBN	0.67	[−0.28, 1.63]	0.355	43.2	1.90	0.129	6
		PND 21	STD - LBN	0.62	[−0.33, 1.57]	0.353	41.9	1.76	0.129	7
		PND 35	STD - LBN	0.77	[−0.21, 1.74]	0.364	47.5	2.11	0.121	8
		PND 56	STD - LBN	0.93	[−0.02, 1.88]	0.352	41.7	2.66	0.045	9
		PND 72	STD - LBN	1.06	[0.10, 2.03]	0.358	44.5	2.97	0.024	10
	AGD		Female - male	−10.35	[−10.48, −10.23]	0.065	239.8	−160.51	<0.001	11
4A	Male serum corticosterone	Pre	CON / ALPS	0.98	[0.71, 1.35]	0.125	121.7	−0.15	0.883	12
		Post	CON / ALPS	0.32	[0.23, 0.44]	0.041	122.2	−8.91	<0.001	13
		CON	Pre / post	0.35	[0.25, 0.47]	0.042	74.1	−8.68	<0.001	14
		ALPS	Pre / post	0.11	[0.08, 0.15]	0.014	73.2	−18.04	<0.001	15
4B	Female serum corticosterone	Di pre	CON / ALPS	1.21	[0.69, 2.13]	0.237	200.2	0.97	0.826	16
		Di post	CON / ALPS	0.31	[0.18, 0.55]	0.061	200.2	−5.98	<0.001	17
		Pro pre	CON / ALPS	0.79	[0.53, 1.18]	0.110	215.8	−1.67	0.387	18
		Pro post	CON / ALPS	0.40	[0.27, 0.59]	0.055	215.8	−6.70	<0.001	19
		Di CON	Pre / post	0.22	[0.13, 0.38]	0.041	109.0	−8.08	<0.001	20
		Di ALPS	Pre / post	0.06	[0.03, 0.10]	0.011	109.0	−14.47	<0.001	21
		Pro CON	Pre / post	0.26	[0.17, 0.41]	0.041	109.0	−8.62	<0.001	22
		Pro ALPS	Pre / post	0.13	[0.09, 0.18]	0.015	109.0	−18.00	<0.001	23
		Pre CON	Diestrus / proestrus	0.68	[0.41, 1.14]	0.120	213.5	−2.16	0.160	24
		Pre ALPS	Diestrus / proestrus	0.45	[0.28, 0.72]	0.074	215.5	−4.85	<0.001	25
		Post CON	Diestrus / proestrus	0.83	[0.50, 1.37]	0.145	213.5	−1.09	0.826	26
		post ALPS	Diestrus / proestrus	1.05	[0.65, 1.70]	0.174	215.5	0.31	0.826	27
4-1A	Body mass		STD - LBN	2.37	[0.16, 4.59]	1.067	21.9	2.22	0.037	28
4-1A	Body mass		CON - ALPS	−0.97	[−1.68, −0.26]	0.353	50.7	−2.75	0.008	29
4-1B	Percentage of change body mass		CON - ALPS	3.66	[3.20, 4.11]	0.229	56.7	16.00	<0.001	30
4-1D	Adrenal mass normalized to body mass		STD - LBN	−0.01	[−0.03, 0.00]	0.007	21.2	−2.01	0.057	31
4-1E	Seminal vesicle mass		CON - ALPS	−12.78	[−27.44, 1.88]	7.295	49.4	−1.75	0.086	32
4-1F	Seminal vesicle mass normalized to body mass		STD - LBN	−0.81	[−1.39, −0.23]	0.278	20.6	−2.91	0.008	33
4-1F	Seminal vesicle mass normalized to body mass		CON - ALPS	−0.51	[−1.02, −0.01]	0.253	52.4	−2.03	0.048	34
4-1G	Testes mass		STD - LBN	15.52	[8.10, 22.94]	3.565	20.8	4.35	<0.001	35
4-1G	Testes mass		CON - ALPS	9.36	[3.25, 15.46]	3.046	55.0	3.07	0.003	36
	Testes mass normalized to body mass		CON - ALPS	0.27	[0.04, 0.49]	0.113	50.6	2.37	0.021	37
4-2B	Percentage of change body mass		Diestrus - proestrus	−0.77	[−1.49, −0.04]	0.365	103.9	−2.10	0.038	38
4-2B	Percentage of change body mass		CON - ALPS	2.83	[2.11, 3.55]	0.363	93.6	7.81	<0.001	39
4-2C	Adrenal mass		STD - LBN	−0.29	[−0.57, 0.00]	0.140	30.6	−2.05	0.049	40
4-2D	Adrenal mass normalized to body mass		CON - ALPS	−0.01	[−0.02, 0.00]	0.005	60.8	−1.76	0.084	41
4-2E	Uterine mass		Diestrus - proestrus	−71.38	[−77.31, −65.46]	2.981	85.5	−23.95	<0.001	42
4-2F	Uterine mass normalized to body mass		Diestrus - proestrus	−2.98	[−3.26, −2.71]	0.138	84.4	−21.62	<0.001	43
4-3B	Male cort admin serum corticosterone	0 h	0 / 2 mg/kg	1.12	[0.78, 1.61]	0.151	172.7	0.86	0.393	44
		1 h	0 / 2 mg/kg	0.14	[0.10, 0.20]	0.019	172.7	−14.72	<0.001	45
		2 h	0 / 2 mg/kg	0.06	[0.04, 0.09]	0.008	172.7	−20.57	<0.001	46
		3 h	0 / 2 mg/kg	0.15	[0.10, 0.21]	0.020	172.7	−14.34	<0.001	47
		4 h	0 / 2 mg/kg	0.10	[0.07, 0.14]	0.013	172.7	−17.18	<0.001	48
		5 h	0 / 2 mg/kg	0.18	[0.13, 0.26]	0.024	172.7	−12.70	<0.001	49
4-3C	Percentage of change body mass		0 − 2 mg/kg	0.68	[−0.02, 1.39]	0.344	27.5	1.99	0.057	50
4-3H	Testes mass		0 − 2 mg/kg	7.28	[1.90, 12.67]	2.613	24.5	2.79	0.010	51
4-3I	Testes mass normalized to body mass		0 − 2 mg/kg	0.13	[−0.02, 0.28]	0.073	24.5	1.80	0.085	52

Holm's method for p value adjustment was used for multiple comparisons. Confidence intervals were adjusted using the more conservative Bonferroni's method. The statistical test used for each outcome is in Table 1.